MEDPASYL: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDPASYL
Largest movements
- Cash +€240,598
up €240,598 (+1409.2%), from €17,073 to €257,671
mainly Current investments (+€223,517) and Investment in fixed assets (net) (+€116,524)
- Current investments -€223,517
no longer reported in 2025 (was €223,517)
- Tangible fixed assets -€116,524
no longer reported in 2025 (was €116,524)
of which Land and buildings: -€97,168
- Receivables within one year +€114,155
up €114,155 (+27179.7%), from €420 to €114,575
of which Other amounts receivable: +€93,718
- Reserves +€58,397
up €58,397 (+94.4%), from €61,860 to €120,257
of which Distributable reserves: +€58,397
- Debts after one year -€31,817
no longer reported in 2025 (was €31,817)
- Tax, wage and social debts +€25,029
up €25,029 (+1251.5%), from €2,000 to €27,029
- Current portion of long-term debt -€19,938
no longer reported in 2025 (was €19,938)
- Trade debts -€14,518
no longer reported in 2025 (was €14,518)
- Gross operating margin +€57,568
up €57,568 (+243.8%), from €23,614 to €81,182
- Taxes +€26,501
up €26,501 (+259.9%), from €10,198 to €36,699
- Depreciation -€17,641
no longer reported in 2025 (was €17,641)
- Financial income +€16,292
up €16,292 (+10511.3%), from €155 to €16,447
- Other operating charges -€1,751
down €1,751 (-84.3%), from €2,076 to €325
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €357,534 | €373,219 | +€15,685 | +4.4% |
| Fixed assets | 21/28 | €116,524 | - | -€116,524 | |
| Tangible fixed assets | 22/27 | €116,524 | - | -€116,524 | |
| Land and buildings | 22 | €97,168 | - | -€97,168 | |
| Plant, machinery and equipment | 23 | €12,469 | - | -€12,469 | |
| Furniture and vehicles | 24 | €6,887 | - | -€6,887 | |
| Current assets | 29/58 | €241,010 | €373,219 | +€132,209 | +54.9% |
| Amounts receivable within one year | 40/41 | €420 | €114,575 | +€114,155 | +27179.7% |
| Trade receivables | 40 | €420 | €20,857 | +€20,437 | +4866.0% |
| Other amounts receivable | 41 | - | €93,718 | +€93,718 | |
| Current investments | 50/53 | €223,517 | - | -€223,517 | |
| Cash at bank and in hand | 54/58 | €17,073 | €257,671 | +€240,598 | +1409.2% |
| Deferred charges and accrued income | 490/1 | - | €974 | +€974 | |
| Total equity and liabilities | 10/49 | €357,534 | €373,219 | +€15,685 | +4.4% |
| Equity | 10/15 | €287,793 | €346,190 | +€58,397 | +20.3% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €61,860 | €120,257 | +€58,397 | +94.4% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €60,000 | €118,397 | +€58,397 | +97.3% |
| Profit (loss) carried forward | 14 | €219,733 | €219,733 | +€0 | 0.0% |
| Amounts payable | 17/49 | €69,741 | €27,029 | -€42,712 | -61.2% |
| Amounts payable after more than one year | 17 | €31,817 | - | -€31,817 | |
| Financial debts | 170/4 | €31,817 | - | -€31,817 | |
| Amounts payable within one year | 42/48 | €37,924 | €27,029 | -€10,895 | -28.7% |
| Current portion of amounts payable after more than one year | 42 | €19,938 | - | -€19,938 | |
| Trade debts | 44 | €14,518 | - | -€14,518 | |
| Suppliers | 440/4 | €14,518 | - | -€14,518 | |
| Taxes, remuneration and social security | 45 | €2,000 | €27,029 | +€25,029 | +1251.5% |
| Taxes | 450/3 | €2,000 | €27,029 | +€25,029 | +1251.5% |
| Other amounts payable | 47/48 | €1,468 | - | -€1,468 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €17,641 | - | -€17,641 | |
| Other operating charges | 640/8 | €2,076 | €325 | -€1,751 | -84.3% |
| Gross operating margin | 9900 | €23,614 | €81,182 | +€57,568 | +243.8% |
| Operating profit (loss) | 9901 | €3,897 | €80,857 | +€76,960 | +1974.8% |
| Financial income | 75/76B | €155 | €16,447 | +€16,292 | +10511.3% |
| Recurring financial income | 75 | €155 | €16,447 | +€16,292 | +10511.3% |
| Financial charges | 65/66B | €2,573 | €2,208 | -€365 | -14.2% |
| Recurring financial charges | 65 | €2,573 | €2,208 | -€365 | -14.2% |
| Profit (loss) for the period before taxes | 9903 | €1,479 | €95,096 | +€93,617 | +6329.8% |
| Income taxes | 67/77 | €10,198 | €36,699 | +€26,501 | +259.9% |
| Profit (loss) for the period | 9904 | -€8,719 | €58,397 | +€67,116 | |
| Profit (loss) for the period to be appropriated | 9905 | -€8,719 | €58,397 | +€67,116 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.